BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32831113)

  • 1. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.
    Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J
    Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas.
    Bostel T; Nicolay NH; Welzel T; Bruckner T; Mattke M; Akbaba S; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2018 Aug; 13(1):154. PubMed ID: 30139357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.
    Uhl M; Edler L; Jensen AD; Habl G; Oelmann J; Röder F; Jäckel O; Debus J; Herfarth K
    Radiat Oncol; 2014 Apr; 9():100. PubMed ID: 24774721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.
    Mima M; Demizu Y; Jin D; Hashimoto N; Takagi M; Terashima K; Fujii O; Niwa Y; Akagi T; Daimon T; Hishikawa Y; Abe M; Murakami M; Sasaki R; Fuwa N
    Br J Radiol; 2014 Jan; 87(1033):20130512. PubMed ID: 24288399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
    Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
    J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
    Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
    Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
    Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
    JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
    Mattke M; Ohlinger M; Bougatf N; Harrabi S; Wolf R; Seidensaal K; Welzel T; Röder F; Gerum S; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Uhl M; Debus J
    Strahlenther Onkol; 2023 Feb; 199(2):160-168. PubMed ID: 36149438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
    Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
    Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.
    Imai R; Kamada T; Araki N;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):322-327. PubMed ID: 27084649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
    Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
    Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy.
    Walser M; Bojaxhiu B; Kawashiro S; Tran S; Beer J; Leiser D; Pica A; Bachtiary B; Weber DC
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e578-e585. PubMed ID: 34340918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of carbon ion radiotherapy in 152 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Kraft G; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):631-40. PubMed ID: 14751537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
    Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study.
    Makishima H; Yasuda S; Isozaki Y; Kasuya G; Okada N; Miyazaki M; Mohamad O; Matsufuji N; Yamada S; Tsuji H; Kamada T;
    Cancer Sci; 2019 Jan; 110(1):303-309. PubMed ID: 30417485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
    Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
    Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.